• Latest Posts

Modulating the Microbiome Could Boost Vaccine Performance

Swedish Alzheimer’s Treatment Slows the Disease in Phase II Trial

Cambridge Biotech Raises €32M Series A Round to Treat Chronic Inflammation

Update: Could Epigenetics Treat Alzheimer’s? A Spanish Biotech May Give Us Answers

Our Eyes Could Open A Window to Diagnosing Alzheimer’s and Parkinson’s Disease

In Depth 29 May 2018

Clinical Trials in Alzheimer’s Disease Are Failing: What Can Be Done?


Celgene Partners With German Biotech to Develop Oncology Treatments

Startup Scout 16 Mar 2018

This Belgian Biotech Could Speed Up Diagnoses for Neurodegenerative Diseases

Can MorphoSys’ Alzheimer’s Treatment Work Where Big Pharma has Failed?

No Nonsense Boehringer Ingelheim Jettisons Failing Alzheimer’s Disease Drug

New Biotech Launched to Fight Cognitive Impairment Caused by Alzheimer’s

Interview 8 Jan 2018

Meet the Swiss CEO Pulling Out All the Stops Against Alzheimer’s Disease